Skip to Content

DPI 894 (Guaifenesin and pseudoephedrine 250 mg / 120 mg)

Pill with imprint DPI 894 is White / Clear, Capsule-shape and has been identified as Guaifenesin and pseudoephedrine 250 mg / 120 mg. It is supplied by Duramed Pharmaceuticals, Inc..

Guaifenesin/pseudoephedrine is used in the treatment of cough and nasal congestion and belongs to the drug class upper respiratory combinations. Risk cannot be ruled out during pregnancy. Guaifenesin/pseudoephedrine 250 mg / 120 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for DPI 894

Guaifenesin and pseudoephedrine 250 mg / 120 mg DPI 894 Front
Guaifenesin and pseudoephedrine 250 mg / 120 mg DPI 894 Back

Guaifenesin and pseudoephedrine

Imprint
DPI 894
Strength
250 mg / 120 mg
Color
White / Clear
Shape
Capsule-shape
Availability
Rx and/or OTC
Drug Class
Upper respiratory combinations
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Duramed Pharmaceuticals, Inc.
National Drug Code (NDC)
51285-0894

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.